Sydney - Tuesday -August 26: (RWE)
----------------------------------
BIOTECH COMPANY ON THE EXPANSION TRAIL
IN LIVER DIAGNOSTIC TECHNOLOGY
Overview:
---------
GOE2 has made a takeover bid for unlisted medical company
called IVB Technology.
In simple terms, IVB uses standard MRI equipment to
measure iron concentration in the liver rather than the very invasive
detection method of inserting a needle between the ribs into the liver
directly.
This method is commonly known as a liver biopsy and has been the
cause of recent deaths.
Doctors around the world are hesitant in using traditional liver
biopsies because of potential legal action.
The new IVB method can be performed regularly in painless
manner, even in infants and children at a cost estimated to be half of a
normal liver biopsy.
The patient can be discharged within 30 minutes rather than have
to stay overnight under the old biopsy method.
Results of the test can be assessed in less than 24 hours rather
than up to 14 days.
A high concentration of iron in the liver, called
haemochromatosis, is mostly a genetic disease, especially in people of
European background.
If left untreated, this iron toxicity is a major cause of organ
damage of the liver [commonly known as fibrosis, cirrhosis], heart
[congestive heart failure and arrhythmia] and the pancreas [diabetes,
and arthritis of the joints].
22 MRI units now incorporate the IVB Technology, including
centres in the USA, South America, Europe, Asia and Australia.
This is expected to increase exponentially when both the US
Federal Drug Administration and the Therapeutic Goods Administration of
Australia adopt its listing.
GEO2 estimates that over 10 million people in Asia, 4 million
people in the USA and 100,000 people in Australia are afflicted with a
form of hereditary iron disorder.
A collaboration with a major US clinic is expected to be
announced in the short term to strengthen long term revenues.
--------------------------------
Share price: 2.3c
Share high/low for year: 2.3c/.07c
Dividend: Nil
----------------------------------
Background:
------------
Geo2 Ltd is an environmental company with unique waste
management material separation technologies, focusing on the treatment
of polluted water, soil remediation, mineral and metail production
processes.
There are 3 main divisions, GeoWater, GeoMetal and GeoFlora.
GeoWater focuses on removing contaminants from water with its
water purification plants, both fixed and mobile, and acid mine drainage
remediation process.
GeoWater also works on separating solids from liquids with the
Clarke IC-SEP technology (an air induced dissolved air flotation
system). and separating liquids from liquids with its second generation
hydrocyclones and oil water separator systems.
GeoMetals main goal is to address the world environment's need for
cleaner processing methods by developing and commercialising
technologies which are socially responsible, ecologically sound and cost
effective.
GEL have developed "demetalisation" technology which will allow
recovery of the precious metals from electronics scrap in a non-waste
producing process and also allow the recycling of the plastic.
GEL have also developed Soil Remediation Technology and Dilute
Leach Technology to combat soil contamination by heavy metals.
The GeoMetals division has two joint ventures operate in China
and a third J.V. has been signed with Metss in the USA which is
transferring our knowledge and technology.
- Forums
- ASX - By Stock
- i expect you know this already - just thought i'd
i expect you know this already - just thought i'd
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)